PharmaCyte Biotech (PMCB) is scheduled to report Q4 earnings on August 10, 2026.
Analyze the earnings history of PharmaCyte Biotech using advanced sorting and filters.
The chart below shows PharmaCyte Biotech's reported EPS compared to analyst estimates over recent quarters.
The chart below shows PharmaCyte Biotech's reported revenue compared to analyst estimates over recent quarters.
PharmaCyte Biotech (PMCB) is scheduled to report earnings on August 10, 2026. The last reported earnings were for reported on March 17, 2026 for Q3.
The Actual EPS was $-0.17, which missed the estimate of $0.00.
The Actual Revenue was $0.00, which hit the estimate of $0.00.